• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Bruce Cree Discusses Multiple Sclerosis Therapy in a Case Management Setting

Article

In this segment, Dr. Bruce Cree, Assistant Professor of Clinical Neurology, Department of Neurology, University of California San Francisco, discusses how he determines the most appropriate medications for his patients, and working with third-party payers.

Deciding which treatment is selected is based upon tolerability and patent preference. It is important to give patient's different treatment options available in managed care plans. Dr. Cree addresses the potential harm of using third-party preferred medications.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Michael Morse, MD, Duke Cancer Center
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.